BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hopkins CR. ACS chemical neuroscience molecule spotlight on Suvorexant. ACS Chem Neurosci 2012;3:647-8. [PMID: 23024835 DOI: 10.1021/cn300086a] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Liu T, Wang C, Zhang X. Synthesis of Chiral Aliphatic Amines through Asymmetric Hydrogenation. Angew Chem Int Ed 2013;52:8416-9. [DOI: 10.1002/anie.201302943] [Cited by in Crossref: 49] [Cited by in F6Publishing: 35] [Article Influence: 5.4] [Reference Citation Analysis]
2 Minehira D, Takahara S, Adachi I, Toyooka N. Laboratory and practical synthesis of Suvorexant, a selective dual orexin receptor antagonist. Tetrahedron Letters 2014;55:5778-80. [DOI: 10.1016/j.tetlet.2014.08.086] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
3 Roecker AJ, Mercer SP, Schreier JD, Cox CD, Fraley ME, Steen JT, Lemaire W, Bruno JG, Harrell CM, Garson SL, Gotter AL, Fox SV, Stevens J, Tannenbaum PL, Prueksaritanont T, Cabalu TD, Cui D, Stellabott J, Hartman GD, Young SD, Winrow CJ, Renger JJ, Coleman PJ. Discovery of 5''-chloro-N-[(5,6-dimethoxypyridin-2-yl)methyl]-2,2':5',3''-terpyridine-3'-carboxamide (MK-1064): a selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia. ChemMedChem 2014;9:311-22. [PMID: 24376006 DOI: 10.1002/cmdc.201300447] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
4 Hoyer D, Jacobson LH. Orexin in sleep, addiction and more: Is the perfect insomnia drug at hand? Neuropeptides 2013;47:477-88. [DOI: 10.1016/j.npep.2013.10.009] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 7.4] [Reference Citation Analysis]
5 Chen Y, Zhou Y, Li J, Sun J, Zhang G. Facile synthesis of suvorexant, an orexin receptor antagonist, via a chiral diazepane intermediate. Chinese Chemical Letters 2015;26:103-7. [DOI: 10.1016/j.cclet.2014.09.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
6 Feng FF, Li JK, Liu XY, Zhang FG, Cheung CW, Ma JA. General Synthesis of Tri-Carbo-Substituted N2-Aryl-1,2,3-triazoles via Cu-Catalyzed Annulation of Azirines with Aryldiazonium Salts. J Org Chem 2020;85:10872-83. [PMID: 32691600 DOI: 10.1021/acs.joc.0c01433] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
7 Dianova LN, Beryozkina TV, Filimonov VO, Fan Z, Slepukhin PА, Bakulev VА. The tandem Dimroth rearrangement and sulfonylation/acylation as regioselective method for the synthesis of 5-arylamino-2-sulfonyland 2-acyl-5-arylamino-1,2,3-triazole-4-carbothioamides. Chem Heterocycl Comp 2020;56:1341-7. [DOI: 10.1007/s10593-020-02820-3] [Reference Citation Analysis]
8 Breidinger S, Simpson R, Mangin E, Woolf E. Determination of suvorexant in human plasma using 96-well liquid–liquid extraction and HPLC with tandem mass spectrometric detection. Journal of Chromatography B 2015;1002:254-9. [DOI: 10.1016/j.jchromb.2015.07.056] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
9 Kishi T, Nomura I, Matsuda Y, Sakuma K, Okuya M, Ikuta T, Iwata N. Lemborexant vs suvorexant for insomnia: A systematic review and network meta-analysis. J Psychiatr Res 2020;128:68-74. [PMID: 32531478 DOI: 10.1016/j.jpsychires.2020.05.025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 5.5] [Reference Citation Analysis]
10 Etori K, Saito YC, Tsujino N, Sakurai T. Effects of a newly developed potent orexin-2 receptor-selective antagonist, compound 1 m, on sleep/wakefulness states in mice. Front Neurosci 2014;8:8. [PMID: 24550770 DOI: 10.3389/fnins.2014.00008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
11 Liu T, Wang C, Zhang X. Synthesis of Chiral Aliphatic Amines through Asymmetric Hydrogenation. Angew Chem 2013;125:8574-7. [DOI: 10.1002/ange.201302943] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
12 Reddy A, Puvvada SC, Kommisetti S, El-mallakh RS, Lippmann S. Suvorexant: something new for sleep? Acta Neuropsychiatr 2015;27:53-5. [DOI: 10.1017/neu.2014.31] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]